Newsroom

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: TIAA-CREF Investment Management, LLC/Teachers Advisors, LLC/Nuveen Asset Management, LLC (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For...

DUBLIN--(BUSINESS WIRE)--The "Global Sickle Cell Disease Treatment Market: Focus on Type, End User, and Country-Level Analysis - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering. The global sickle cell disease treatment market is expected to experience substantial growth, driven by the increasing prevalence of sickle cell disease and the rising demand for more effective and accessible treatments. North America, particularly the U.S., leads the market...

VANCOUVER, British Columbia--(BUSINESS WIRE)--WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the “Company” or “WELL”), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce that at its annual general meeting held June 30, 2025 (the “Meeting”), all of the nominees for election as directors of the Company referred to in its notice of meeting and infor...

DUBLIN--(BUSINESS WIRE)--The "Fusion Energy Market - A Global and Regional Analysis: Focus on Application, Technology, Fuel Cycle, and Country Analysis - Analysis and Forecast, 2025-2034" report has been added to ResearchAndMarkets.com's offering. The global fusion energy market is characterized by a dynamic ecosystem of large-scale international collaborations, government-backed research consortia, and a burgeoning cadre of private ventures, all converging on magnetic confinement (tokamaks and...

DUBLIN--(BUSINESS WIRE)--The "Immunomodulator Therapeutics Market, Global, 2024-2030" report has been added to ResearchAndMarkets.com's offering. Revenue estimate for the base year 2024 is $93 billion with a CAGR of 9.0% for the study period 2024-2030. This research service offers a comprehensive analysis of the global immunomodulator therapeutics market, specifically targeting inflammatory disorders in the immunology, gastrointestinal (GI), and dermatology segments. The report defines this mar...

DUBLIN--(BUSINESS WIRE)--The "Medium and Heavy-duty Commercial Vehicle (CV) Electronic Service Tools (EST) Market, North America, 2025-2030" report has been added to ResearchAndMarkets.com's offering. The North American medium and heavy-duty commercial vehicle (CV) electronic service tools (EST) market is experiencing gradual and sustained growth, driven by interesting industry dynamics, such as advancements in vehicle complexity, a growing focus on vehicle efficiency and fuel economy, the incr...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.   (c) Name o...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.   (c) Name o...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Nasdaq Cybersecurity UCITS ETF 03.07.2025 NQCYBREN IE00BF16M727 25,925,425.00 USD 1,234,882,711.84 47.632  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust NYSE Arca Biotechnology UCITS ETF 03.07.2025 FBTU.LN IE00BL0L0H60 525,002.00 USD 10,589,470.30 20.170  ...